Allogene Therapeutics Cash from Investing (TTM) Insights

Allogene Therapeutics Inc (ALLO)

3.45 -0.06 (-1.71%) USD | NASDAQ | Apr 18, 16:00

3.46 +0.01 (+0.29%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	163.29M
September 30, 2023	145.42M
June 30, 2023	204.60M
March 31, 2023	241.47M
December 31, 2022	106.16M
September 30, 2022	85.81M
June 30, 2022	73.92M
March 31, 2022	44.48M
December 31, 2021	163.66M
September 30, 2021	156.62M
June 30, 2021	60.25M

Date	Value
March 31, 2021	-393.32M
December 31, 2020	-505.12M
September 30, 2020	-519.40M
June 30, 2020	-357.27M
March 31, 2020	116.19M
December 31, 2019	164.08M
September 30, 2019	-157.23M
June 30, 2019	-552.78M
March 31, 2019	-599.91M
December 31, 2018	-632.80M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-552.78M

Minimum

Jun 2019

241.47M

Maximum

Mar 2023

-39.96M

Average

85.81M

Median

Sep 2022

Cash from Investing (TTM) Benchmarks